AbbVie's Promising Leap Towards Long-Term Growth: Analyst - AbbVie (NYSE:ABBV)
Raymond James initiated coverage on AbbVie Inc (NYSE: ABBV) as the company looks beyond Humira's loss of exclusivity and has several levers to set up long-term growth.
Source: benzinga.com